Bumetanide and Kineret drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bumetanide (bumetanide) and Kineret (anakinra). Common drug interactions include drug ineffective among females and blood urea increased among males.

The phase IV clinical study analyzes what interactions people have when they take Bumetanide and Kineret. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

What is Kineret?

Kineret has active ingredients of anakinra. It is often used in rheumatoid arthritis. eHealthMe is studying from 11,120 Kineret users. Check the latest studies of Kineret.

On Jul, 10, 2026

32 people who take Bumetanide and Kineret together, and have interactions are studied.

Bumetanide and Kineret drug interactions.

What are the common drug interactions of Bumetanide and Kineret, by gender? *:

female:

Drug ineffective
Fatigue (feeling of tiredness)
Poor quality sleep
Impaired work ability
Body tinea (ringworm of the body)
Bone density decreased
Cataract (clouding of the lens inside the eye)
Cellulitis (infection under the skin)
Contusion (a type of hematoma of tissue in which capillaries)
Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)

male:

Blood urea increased
Decreased appetite
Respiratory failure (inadequate gas exchange by the respiratory system)
Tachypnoea (a condition of rapid breathing over 20 per minute)
Dyspnoea (difficult or laboured respiration)
Hyperlactacidaemia (the acidosis and also reduces the capacity of the kidney)
Hypocapnia (level of carbon dioxide in the blood is lower than normal)
Hypoxia (low oxygen in tissues)
Inflammation
Lymphopenia (an abnormally low level of lymphocytes in the blood)

What are the common drug interactions of Bumetanide and Kineret, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Abscess (pus)
Bradycardia (abnormally slow heart action)
Diarrhoea
Heart rate decreased
Influenza like illness
Vomiting

50-59:

Drug ineffective
Fatigue (feeling of tiredness)
Poor quality sleep
Impaired work ability
Body tinea (ringworm of the body)
Bone density decreased
Cataract (clouding of the lens inside the eye)
Cellulitis (infection under the skin)
Contusion (a type of hematoma of tissue in which capillaries)
Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)

60+:

Blood urea increased
Decreased appetite
Respiratory failure (inadequate gas exchange by the respiratory system)
Tachypnoea (a condition of rapid breathing over 20 per minute)
Arrhythmia (irregular heartbeat)
Burning sensation
Peripheral swelling
Pruritus (severe itching of the skin)
Skin discolouration (change of skin colour)
Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

Complex Regional Pain Syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet)): 24 people, 75.00%
Migraine (headache): 23 people, 71.88%
Insomnia (sleeplessness): 12 people, 37.50%
Hyperlipidaemia (presence of excess lipids in the blood): 10 people, 31.25%
Neck Pain: 2 people, 6.25%
Immunodeficiency Disorders: 2 people, 6.25%
Immunodeficiency Common Variable: 2 people, 6.25%
Chondrocalcinosis (crystal deposition disease): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and Kineret?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously